These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33170119)

  • 41. Association of the exoU genotype with a multidrug non-susceptible phenotype and mRNA expressions of resistance genes in Pseudomonas aeruginosa.
    Takata I; Yamagishi Y; Mikamo H
    J Infect Chemother; 2018 Jan; 24(1):45-52. PubMed ID: 29107652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secondary in-hospital epidemiological investigation after an outbreak of Pseudomonas aeruginosa ST357.
    Mihara T; Kimura T; Momiyama K; Kainuma A; Akiyama K; Ohara J; Inoue K; Kinoshita M; Shimizu M; Moriyama K; Fujita N; Sawa T
    J Infect Chemother; 2020 Mar; 26(3):257-265. PubMed ID: 31680038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The Prevalence of Metallo-β-Lactamases and Efflux-Mediated Mechanisms in Carbapenem Nonsusceptible Nosocomial Pseudomonas aeruginosa Isolated in Moscow in 2012-2015].
    Vestn Ross Akad Med Nauk; 2015; (6):679-83. PubMed ID: 27093795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.
    Wong-Beringer A; Wiener-Kronish J; Lynch S; Flanagan J
    Clin Microbiol Infect; 2008 Apr; 14(4):330-6. PubMed ID: 18190571
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigating of four main carbapenem-resistance mechanisms in high-level carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Rostami S; Farajzadeh Sheikh A; Shoja S; Farahani A; Tabatabaiefar MA; Jolodar A; Sheikhi R
    J Chin Med Assoc; 2018 Feb; 81(2):127-132. PubMed ID: 29033110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia.
    Garey KW; Vo QP; Larocco MT; Gentry LO; Tam VH
    J Chemother; 2008 Dec; 20(6):714-20. PubMed ID: 19129069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between Biofilm Formation and Antimicrobial Resistance in Carbapenem-Resistant
    Cho HH; Kwon KC; Kim S; Park Y; Koo SH
    Ann Clin Lab Sci; 2018 May; 48(3):363-368. PubMed ID: 29970441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High mortality outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a Brazilian pediatric oncology hospital.
    Quiles MG; Carlesse F; da Silva MA; Mingrone RC; Fonseca JM; Silva DC; Pignatari AC
    Braz J Infect Dis; 2017; 21(2):205-206. PubMed ID: 27986489
    [No Abstract]   [Full Text] [Related]  

  • 49. Carbapenem-resistant-only Pseudomonas aeruginosa infection in patients formerly infected by carbapenem-susceptible strains.
    Tsai MH; Wu TL; Su LH; Lo WL; Chen CL; Liang YH; Chiu CH
    Int J Antimicrob Agents; 2014 Dec; 44(6):541-5. PubMed ID: 25264129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.
    Park MH; Kim SY; Roh EY; Lee HS
    Auris Nasus Larynx; 2017 Jun; 44(3):258-265. PubMed ID: 27461174
    [TBL] [